Street View: Boeing's path to recovery lengthens despite improving factory performance

Boeing

Wed 07:58

** Boeing BA.N posted a Q3 loss of 26 cents per share on Tuesday and said it will miss 2026 targets for 737 production and deliveries, as weakness in commercial jet business outweighed stronger margins elsewhere
     
DELAYED, NOT DERAILED
** Morgan Stanley ("equal-weight," PT: $195) says rising production costs and supply-chain pressures could renew investor scrutiny of BA's path to long-term cash-flow targets, even as manufacturing trends continue to improve
** J.P. Morgan ("overweight," PT: $240) says "new targets look more achievable, but the proof will be in the execution"
** TD Cowen ("buy," PT: $210) says new cash-flow targets effectively push out consensus expectations by a year, underscoring a slower-than-expected production recovery
** RBC ("outperform," PT: $235) says focus is likely to shift to Boeing's 2027 cash-flow outlook and timing of further 737 production increases, as recovery takes longer than expected

 (Reporting by Rashika Singh in Bengaluru)
 ((rashika.singh@thomsonreuters.com))